Cargando…
FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer
Background. At present, EC staging is based on the WHO conservative criteria, which only consider the percentage of gland formation. The molecular subgrouping of EC recently proposed by the Cancer Genome Atlas (TCGA) represents a milestone in precise molecular-based patient triage. The present study...
Autores principales: | Adamczyk-Gruszka, Olga, Horecka-Lewitowicz, Agata, Gruszka, Jakub, Wawszczak-Kasza, Monika, Strzelecka, Agnieszka, Lewitowicz, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504491/ https://www.ncbi.nlm.nih.gov/pubmed/36143062 http://dx.doi.org/10.3390/jcm11185416 |
Ejemplares similares
-
The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022) -
Endometrial Cancer in Aspect of Forkhead Box Protein Contribution
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022) -
A New Aberration in the VPS33B Gene Leads to Full-Symptom ARCS1
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2021) -
CD63 and GLUT-1 Overexpression Could Predict a Poor Clinical Outcome in GIST: A Study of 54 Cases with Follow-Up
por: Lewitowicz, Piotr, et al.
Publicado: (2016) -
HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion
por: Lewitowicz, Piotr, et al.
Publicado: (2019)